Trial intelligence / Profile preview

Clofibrate and zinc sulfate for neonatal jaundice

IRCT20210922052558N1Phase 3Completed

Sponsor
Aja University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of clofibride and zinc in jaundice (4 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Bilirubin level. Started Apr 2022; status: completed.

02

Drugs

clofibridezinc
03

Conditions

jaundice

Beyond the preview

Go deeper on IRCT20210922052558N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210922052558N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call